The CEO of Eli Lilly & Co. (NYSE:LLY), John Lechleiter, has this to say, “Many companies are seeking to lower risk by reducing their focus on innovative medicines. This is not our path.”
Bristol Myers Squibb Co. (NYSE:BMY) shares are down in the $19 range and down 3% in the last month. Bristol-Myers Squibb is a moderate-risk stock at this point.
Thanks for visiting WallStNation.com, to assist your investing research try using our Search (click to access) or review the list of Tickers (click to access) that link directly to articles related to the given stock/security.
To Browse our Most Recent Stories (click here)
Please Review the WallStNation.com Disclaimer and remember that information provided by our site is at the investor's sole financial risk. Please Review for more Details
Advertise on the Nation for just $15 per Week - Click to Learn More>>
Advertise on WallStNation.com - Click to Learn More>>